preloaderlogo please wait

We Are Lumen Value & Access

Brighter Evidence, Brighter Outcomes

Lumen Value & Access

We illuminate the path to improved access and outcomes; creating value through effective evidence generation and compelling communications.

We are part of the Healthcare Consultancy Group, a global forward-thinking leader in medical communications, crafting evidence into stories that shapes decisions and drives medicine.

Lumen Value & Access is led by industry experts, underpinned by real-world data and scientific rigor and driven by strategic planning, proven evidence generation methodologies, and effective value communication.
 

75+

Years of Combined Experience

18

Therapeutic Areas

25

Major Pharmaceutical Clients

5

Global Regions

Scientific Expertise, Global Experience, & A Proven Track Record

PHARMACEUTICALS

BIOTECHNOLOGY

HEALTH POLICY

DEVICE & DIAGNOSTICS

Our compelling services facilitate successful patient access through evidence generation and value demonstration

Senior Leadership

Canter Martin, MBA
EVP, Managing Director

With over 20 years experience in senior HEOR & RWE leadership roles, Canter leads our group to provide clients with the path to access & improved patient outcomes through strategic planning, proven evidence generation methodologies, & effective value communications. His team is inspired to answer client’s most challenging clinical & commercial questions, as well as meet the highest standards of project delivery & compliance.
Canter also oversees HCG’s HEOR & RWE strategic partnerships with the industry’s leading health services & data providers to drive innovation & support our clients’ needs in a dynamic global market.

Kathy Belk
VP, RWE & Data Analytics

Kathy is a health services researcher with more than 20 years of experience managing real-world datasets and utilizing real-world data for clinical & economic research. She has extensive experience leading data-driven projects for pharmaceutical & medical device companies using many research designs across many therapeutic areas. Her research has been presented at national & international scientific conferences & published in peer-reviewed journals. Kathy also has experience with hospital quality initiatives, previously serving as analytics lead for a pay-for-performance demonstration pilot project with the Centers for Medicare & Medicaid Services.

Phillip Hivale
US Market Access Lead

Dr. Phillip Hivale has 10 + years in managed markets, value-based contracting, FDA/BLA policies, access and reimbursement, brand strategy, and health and economic outcomes. He has collaborated alongside numerous healthcare stakeholders and formulary decision-makers to gain consumer insights across payers, IDNs, and health systems. He has also worked directly with a number of pharmaceutical manufacturers to optimize their market access strategy and overall value messaging. Within a dynamically changing market, Phillip’s critical understanding of clinical and budget impact within the healthcare system has allowed him to provide an extremely unique expertise for each one of his clients.

Ramiro Gilardino
Global Market Access Lead

Dr. Ramiro Gilardino brings 12+ years of experience in health economics, outcomes research, and global health policy in pharmaceutical, medical devices companies, and not-for-profit organizations both at the regional and global reach.
He developed customer-centered value propositions, registry studies, claims analysis, among several market access and health economics tactics supporting access to medical technologies. He also was engaged in health policy matters, including health technology assessment policies, patient engagement, and value assessment, where he worked among decision-makers in Europe and emerging markets in LATAM and CEMEA.

Contact Us

EUROPE

Ramiro Gilardino, MD, MHS, MSc
Senior Director, Global Market Access
Pricing & Value Communication
ramiro.gilardino@hcg-int.com
+44 2036 550716

US

Kathy Belk
VP, Real-World Evidence & Data Analytics
Global Operations Lead
kathy.belk@hcg-int.com
+1 704 707 6165